NCM · Biotechnology

Silo Pharma, Inc. (SILO) Stock

$1.47 +1.38% NCM: SILO Healthcare

Valuation

MetricValue
Price$1.47
Market Cap$1.66M
P/E Ratio-0.27
P/B Ratio0.33
P/S Ratio30.43
EPS (TTM)$-0.50
52-Week High$10.88
52-Week Low$1.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-81.74%
ROA-75.13%
ROCE-91.31%
Gross Margin-3.29%
Operating Margin-66.31%
Net Margin-67.17%
Debt/Equity0.00
Current Ratio7.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-4.0M$-4.0M$-5.0M$-4.0M
Net Profit$4.0M$-4.0M$-4.0M$-4.0M$-4.0M
EPS$19.50$-25.65$-18.00$-17.85$-7.50
Op Margin-3850.9%-5031.3%-5347.4%-6526.4%-5936.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$12.0M$8.0M$7.0M$8.0M
Total Liabilities$1.0M$1.0M$2.0M$2.0M$1.0M
Cash$10.0M$11.0M$4.0M$4.0M$5.0M
Borrowings$0$0$0$0$0

Latest News

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? Insider Monkey · Jul 15, 2026 Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform InvestorsHub · Jul 14, 2026 Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform GlobeNewswire · Jul 14, 2026 Top Midday Decliners MT Newswires · Jul 10, 2026 Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO) InvestorsHub · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-3.0M$-3.0M$-4.0M$-5.0M
Investing Cash Flow$7.0M$0$-4.0M$1.0M$1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$9.0M$2.0M$-8.0M$0$1.0M
Free Cash Flow$-2.0M$-3.0M$-3.0M$-4.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.36
FCF Yield-202.99%
Quick Ratio5.36
Interest Coverage-112.03
Return 1Y-43.48%
Return 3Y-84.07%
Return 5Y-96.75%

Ownership

Insiders Held16.41%
Institutions Held11.13%
Institutions Float Held13.31%
Institutional HolderSharesReport Date
AdvisorShares Investments, LLC44,2652026-03-31
FNY Investment Advisers, LLC37,5072026-06-30
Geode Capital Management, LLC12,0022026-03-31
Susquehanna International Group, LLP4,1862026-03-31
Jane Street Group, LLC2,9842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDRXBiodexa Pharmaceuticals Plc $1.71 -3.39% 0.00 $1.28M 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CMNDClearmind Medicine Inc. $6.58 -0.30% -0.51 $1.22M 0.00%
CNSPCNS Pharmaceuticals, Inc. $5.35 +0.00% -0.23 $7.82M 0.00%
GRIGRI Bio, Inc. $1.74 +3.57% -0.04 $3.80M 0.00%

About Silo Pharma, Inc.

Silo Pharma, Inc. is led by CEO Eric Weisblum, employs 3 people, headquartered in US, publicly traded since 2021.

Silo Pharma, Inc. (SILO) stock trades at $1.47 with a market capitalization of $1.66M. The stock is valued at a price-to-earnings (P/E) ratio of -0.27, price-to-book of 0.33, price-to-sales of 30.43. Over the past 52 weeks the stock has ranged between $1.39 and $10.88, and currently trades 86.5% below its 52-week high.

On profitability, Silo Pharma, Inc. generates a return on equity (ROE) of -81.74%, return on capital employed of -91.31%, an operating margin of -66.31%, a net profit margin of -67.17%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides